EMERGENT BIOSOLUTIONS INC. COMMON STOCK
9.4800
22-November-24 15:29:59
15 minutes delayed
Stocks
+0.0800
+0.85%
Today's range
9.3700 - 9.6700
ISIN
N/A
Source
NYSE
-
Emergent BioSolutions Announces Organizational Changes as Part of Sharpened Strategic Focus
09 Jan 2023 05:59:00 By Nasdaq GlobeNewswire
-
05 Jan 2023 16:30:00 By Nasdaq GlobeNewswire
-
06 Dec 2022 05:00:00 By Nasdaq GlobeNewswire
-
14 Nov 2022 05:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results For Third Quarter 2022
08 Nov 2022 15:16:51 By Nasdaq GlobeNewswire
-
01 Nov 2022 15:05:14 By Nasdaq GlobeNewswire
-
18 Oct 2022 05:30:00 By Nasdaq GlobeNewswire
-
26 Sep 2022 15:12:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate
06 Sep 2022 05:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
10 Aug 2022 05:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results for Second Quarter 2022
01 Aug 2022 15:05:47 By Nasdaq GlobeNewswire
-
18 Jul 2022 15:05:00 By Nasdaq GlobeNewswire
-
07 Jul 2022 15:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors
06 Jul 2022 15:05:00 By Nasdaq GlobeNewswire
-
24 Jun 2022 05:30:00 By Nasdaq GlobeNewswire
-
21 Jun 2022 05:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
02 Jun 2022 07:20:49 By Nasdaq GlobeNewswire
-
16 May 2022 05:32:17 By Nasdaq GlobeNewswire
-
12 May 2022 05:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results For First Quarter 2022
28 Apr 2022 15:05:36 By Nasdaq GlobeNewswire